Technology Overview & Start-up Scouting for Development of Allogeneic iPSCs
A clinical-stage biopharmaceutical company approached Stellarix to get a technology and innovation overview in the allogeneic iPSCs segment. Our strategic intelligence helped the client gain a future outlook on allogeneic iPSCs development with HLA/MHC knockdown, reforming its market and business strategy. Client Background: Clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent […]